Scleroderma Recruiting Phase 3 Trials for Domperidone (DB01184)

Also known as: Dermatosclerosis

IndicationStatusPhase
DBCOND0013449 (Scleroderma)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01878526Gastroesophageal Reflux Treatment in SclerodermaTreatment